What is the risk of antithrombotic therapy within the first 24 hours after treatment with alteplase and mechanical thrombectomy?
The risk of antithrombotic therapy within the first 24 hours after treatment with IV alteplase (with or without mechanical thrombectomy) is uncertain. Use might be considered in the presence of concomitant conditions for which such treatment given in the absence of IV alteplase is known to provide substantial benefit or withholding such treatment is known to cause substantial risk.